You are subscribed to the Drug Topics Community Pharmacists' Report. Unsubscribe here.

Drug Topics Community Pharmacists' Report

Print Subscribe

Digital Edition Subscribe

December 11, 2012

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

Top article

Qualitest recalls hydrocodone/acetaminophen tablets

Qualitest, a subsidiary of Endo Health Solutions, issued a voluntary nationwide recall Dec. 6 for 101 lots of hydrocodone bitartrate and acetaminophen tablets, USP 10 mg/500 mg, due to the potential for oversized tablets. » More

Continuing Education

New CPE Series: December activity available now

Welcome to the fourth activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The December activity will cover insulin therapy for diabetes care management.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Today's Headlines

New APhA-APPM interest groups invite participants

Members of American Pharmacists Association Academy of Pharmacy Practice and Management (APhA-APPM) are working to form three new Special Interest Groups (SIG) that focus on compounding, diabetes management, and immunizing pharmacists. » More

Rite Aid to deliver immunization record to providers

All 4,600 Rite Aid pharmacies will be able to deliver a notification of a patient's immunizations to the patient's healthcare provider through the use of secure electronic exchange, according to a press release from Surescripts. » More

No benefit with longer treatment for male UTI

When men are treated for a longer-duration antibiotic therapy for urinary tract infection (UTI), there is no decrease in early recurrence compared with those treated for a shorter duration, according to a study online in Archives of Internal Medicine. » More

TAKE OUR SURVEY

Are you a member of any LinkedIn pharmacy groups?

- Yes
- No

Click Here to let us know.

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Advertisement

Check these out too

QS/1 partners with CoverMyMeds

Heparin label must state total Rx strength

Ondansetron (Zofran) dose recalled

FDA: Zytiga for late-stage prostate cancer

Voices

Anticoagulation Update

JP at Large: Just Another Night at the Pharmacy

View from the Zoo: How to solve every problem in pharmacy

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group